跳至主要内容
临床试验/NCT03617419
NCT03617419已完成不适用

Evaluation of Feasibility and Accuracy of Assisted Fetal Heart Rate (FHR) Feature of the GE Vscan Access R2 Ultrasound System

GE Healthcare2 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2017年11月14日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
GE Healthcare
入组人数
16
试验地点
2
主要终点
Difference in Fetal Heart Rate as Measured by VScan Access R2 and Corometrics

研究概览

简要总结

This study is being done to evaluate if the Vscan Access R2 Ultrasound System can measure Fetal Heart Rate (FHR) in humans when compared against a reference device (GE Corometrics 170 Series Fetal Monitor), and to gather feedback from device operators on the usability of the device.

详细描述

This study is being done to evaluate whether the Vscan Access R2 Ultrasound System Assisted FHR phantom testing conclusions can be extrapolated onto human fetal heart rate measurements, where CTG (GE Corometrics 170 Series Fetal Monitor) is to provide a reference value. It should be noted that the Vscan Access R2 Ultrasound System with Assisted FHR has a different intended use than CTG (momentary FHR value versus continuous monitoring of FHR patterns and trends) and this aspect is out of scope of this research.

Usability data will be gathered for further user experience optimization.

研究设计

研究类型
Interventional
干预模型
Sequential
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women aged 18 years or older at the time of consent;
  • By self-report, are in the 2nd or 3rd trimester of pregnancy;
  • Able and willing to provide written informed consent for participation;
  • Provide a completed Healthcare Verification Form which confirms the subject has received at least one diagnostic ultrasound during this pregnancy and has an uncomplicated pregnancy.

排除标准

  • Are direct employees/contractors of General Electric (GE);
  • Are potentially put at additional risk by participating, in the opinion of study staff;
  • Twin pregnancies identified in patient medical history.

研究组 & 干预措施

VScan Access R2 Ultrasound System

Other

Pre-market: Vscan Access R2 Ultrasound System

The following post-market products will be used on label:

GE Corometrics 170 Series Fetal Monitor - as a reference for value of fetal heart rate GE Voluson P8 Ultrasound System - for verification of fetal location during measurement

干预措施: GE VScan Access R2 Ultrasound System (Device)

VScan Access R2 Ultrasound System

Other

Pre-market: Vscan Access R2 Ultrasound System

The following post-market products will be used on label:

GE Corometrics 170 Series Fetal Monitor - as a reference for value of fetal heart rate GE Voluson P8 Ultrasound System - for verification of fetal location during measurement

干预措施: GE Corometrics 170 Series Fetal Monitor (Device)

结局指标

主要结局

Difference in Fetal Heart Rate as Measured by VScan Access R2 and Corometrics

时间窗: 1 day - Up to 45 minutes of total scan time

Absolute difference and variance in fetal heart rate (in BPM) measured using VScan Access R2 and Corometrics

次要结局

  • GE Voluson P8 Confirmation of Visualization of Fetal Heart With Yes/No Answer Per Subject(1 day - Up to 45 minutes of total scan time (5 minutes for this specific measurement))

研究者

发起方
GE Healthcare
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验